Biotech ETFs Mixed After Gilead Subpoena
June 13, 2011 at 13:53 PM EDT
Biotechnology exchange traded funds were mixed Monday after sector bellwether Gilead Sciences (NasdaqGS: GILD) disclosed it has received a subpoena from the U.S. Department of Justice. Gilead shares were down nearly 1% but pared their earlier loss after the company late Friday said it has received...
